SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-010616
Filing Date
2024-02-05
Accepted
2024-02-05 16:15:09
Documents
1
Group Members
ALTITUDE LIFE SCIENCE VENTURES II, LLCALTITUDE LIFE SCIENCE VENTURES SIDE FUND II, L.P.DAVID MAKI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245170d1_sc13ga.htm SC 13G/A 109222
  Complete submission text file 0001104659-24-010616.txt   111061
Mailing Address 701 FIFTH AVENUE, SUITE 5400 SEATTLE WA 98074
Business Address 701 FIFTH AVENUE, SUITE 5400 SEATTLE WA 98074 650-843-5294
Altitude Life Science Ventures Fund II, L.P. (Filed by) CIK: 0001638820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Subject) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91982 | Film No.: 24595890
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)